CONOR MEDSYSTEMS RECEIVES APPROVAL FOR ONE-YEAR SHELF LIFE FOR COSTAR STENT IN THE EUROPEAN UNION

Conor Medsystems, Inc., a developer of innovative, controlled vascular drug delivery technologies, announced that the company has received regulatory approval for extending the shelf life of Conor's CoStar cobalt chromium paclitaxel-eluting stent in the European Union to twelve months from the current shelf life of six months.

Yahoo News (http://biz.yahoo.com/prnews/061005/sfth013.html?.v=74)